Dong-Il Kim
Net worth: 4 750 $ as of 30/01/2026
Net worth: 4 750 $ as of 30/01/2026
Dong-Il Kim is currently a Professor at Inha University since 2012.
Formerly, Dr. Kim was an Independent Director at SunBio, Inc. and Celltrion, Inc. Education includes a doctorate from Rutgers State University of New Jersey conferred in 1989, a graduate degree from Massachusetts Institute of Technology conferred in 1986, and both undergraduate and graduate degrees from Seoul National University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SUNBIO, INC. 0.01% | 29/09/2025 | 1,250 ( 0.01% ) | 4 750 $ | 30/01/2026 |
| Companies | Position | Start |
|---|---|---|
Inha University
Inha University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 31/05/2011 |
| Companies | Position | End |
|---|---|---|
| SUNBIO,INC. | Director/Board Member | - |
| CELLTRION, INC. | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SunBio, Inc.
SunBio, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies biopharmaceuticals, bio-similars and medical devices | Health Technology |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inha University
Inha University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celltrion, Inc.
Celltrion, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition